AJMC September 4, 2024
Skylar Jeremias

Steve Pickette, PharmD, BCPS, explains that artificial intelligence (AI)–driven formulary analysis can significantly enhance the efficiency and accuracy of drug selection processes by rapidly compiling and analyzing evidence.

Steve Pickette, PharmD, BCPS, chief clinical pharmacist at InpharmD, explains that artificial intelligence (AI)–driven formulary analysis can significantly enhance the efficiency and accuracy of drug selection processes by rapidly compiling and analyzing evidence, although it requires careful oversight to mitigate risks related to data bias, privacy, and AI inaccuracies.

At The American Journal of Managed Care®’s Institute for Value-Based Medicine (IVBM) event in Seattle, Washington, cohosted with Providence, Pickette presented on the use of AI in formulary management. The IVBM event highlighted integrative approaches in neuroscience population health, with additional presentations on...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: AI (Artificial Intelligence), Conferences / Podcast, Pharma, Pharma / Biotech, Technology, Trends
Related Articles:
Cofactor AI Nabs $4M to Combat Hospital Claim Denials with AI
Set Your Team Up to Collaborate with AI Successfully
What’s So Great About Nvidia Blackwell?
Mayo develops new AI tools
Medtronic, Tempus testing AI to find potential TAVR patients

Share This Article